Evidence map›Paper›PMID 18043247›Full record

ReviewCurrent opinion in hematology2008

Basophils and type 2 immunity.

Booki Min, William E Paul

Abstract readReview
In one paragraph

Review in Current opinion in hematology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Basophils in atopic dermatitis: Immunologic roles and clinical implications.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Booki MinDepartment of Immunology/NB30, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
William E Paul
Cleveland Clinic · USGTx (United States) · US

Funding

INTERLEUKIN 4 (IL-4)Z01AI000493 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI PAUL, WILLIAM · 1987 to 2008
$3.1M
Intramural NIH HHS Z01 AI000493
6 · The paper itself

Abstract

purpose of reviewMechanisms involved in the development of in-vivo type 2 immunity are poorly defined. Basophils are potent IL-4-producing cells and may contribute to the process of polarizing immune responses. RECENT

findingsAlthough basophils represent fewer than 0.5% of blood leukocytes, their frequency dramatically increases under certain circumstances, particularly Th2-related responses including parasitic infection and allergic inflammation. Recent studies proposed the hypothesis that basophils could contribute to the development of type 2 immunity by providing initial IL-4 important in T cell polarization and by recruiting other effector cells such as eosinophils or neutrophils. Multiple stimuli of IgE-dependent and IgE-independent pathways that lead to release of cytokines and mediators from activated basophils have been identified. In addition, progenitors that differentiate into mature basophils have recently been identified. SUMMARY: The current review revisits basophils with the goal of providing insights into understanding unappreciated roles of basophils in vivo.

Indexed as

AnimalsBasophilsCell Adhesion MoleculesCell DifferentiationCell MovementCytokinesHIV InfectionsHumansImmunoglobulin EInflammationInterleukin-4MiceParasitic DiseasesReceptors, IgETh2 CellsCell Adhesion MoleculesCytokinesImmunoglobulin EInterleukin-4Receptors, IgE

Identifiers

PMID18043247
PMCPMC3403736
OpenAlexW2151270085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.